Skip to main content

Table 1 Patient demographics and clinical data

From: Efficacy and safety of selective renal arterial embolization in renal angiomyolipoma: a prospective single-center study

Variables Data, N (%)
No. of patients 33
Gender  
Male 9 (27.3)
Female 24 (72.7)
Type of AMLs  
Single 15 (45.5)
Multiple 18 (54.5)
Laterality of AMLs  
Unilateral 17 (51.5)
Right 9 (27.3)
Left 8 (24.2)
Bilateral 16 (48.5)
TSC status  
Yes 12 (36.4)
No 21 (63.6)
Other comorbidities  
Diabetes mellitus (DM) 6 (18.2)
HTN 10 (30.3)
Hepatic 1 (3)
Cardiac 1 (3)
Past history  
Previous SAE 4 (12.1)
Need for blood transfusion  
No need 7 (21.2)
Need 26 (78.8)
TSC features 12
Family history 2 (16.7)
Vogt triad 12 (100)
Seizures 12(100)
Intellectual disability 9 (75)
Adenoma sebaceum 10 (83.3)
Associated other lesions 12
Cortical or subependymal brain tubers 12 (100)
Pulmonary LAMs 2 (16.7)
Hepatic AMLs 8 (66.7)
No. of embolized renal AMLs with SAE 35
Type of AMLs  
TSC-associated 15 (42.9)
Sporadic 20 (57.1)
Classification of AMLs  
Fat rich 33 (94.3)
Fat-poor 2 (5.7)
Fat-invisible 0
Side of AMLs  
Right 20 (57.1)
Left 15 (42.9)
Presentation of AMLs  
Asymptomatic 5 (14.3)
Symptomatic 30 (85.7)
Type of SAE  
Prophylactic 3 (8.6)
Emergency 29 (82.8)
Pre-operative 3 (8.6)
Indications  
Pain 35 (100)
Size 35 (100)
Composition 4 (11.4)
Bleeding symptoms 30 (85.7)
Hematuria 12 (34.3)
Intra-lesional bleeding 27 (77.1)
Retro-peritoneal bleeding 20 (57.1)
Presence of vascular anomalies  
Yes 34 (97.1)
Micro-aneurysms 9 (25.7)
Aneurysms 24 (68.5)
AVM 1 (2.9)
No 1 (2.9)
Embolic material used  
Microcoils 20 (57.2)
Microspheres 4 (11.4)
Microspheres and microcoils 7 (20)
Absolute alcohol and microcoils 4 (11.4)